Difenoxin and Atropine and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Difenoxin and Atropine and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: atropine / difenoxin
Brand name: Motofen
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Difenoxin and Atropine-Insulin glargine, recombinant Subcutaneous
- Difenoxin and Atropine-Insulin glulisine
- Difenoxin and Atropine-Insulin Glulisine (Cartridges and Pens)
- Difenoxin and Atropine-Insulin Glulisine (Vials)
- Difenoxin and Atropine-Insulin glulisine Subcutaneous
- Difenoxin and Atropine-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Differin
- Insulin glargine and lixisenatide Subcutaneous-Differin (Adapalene)
- Insulin glargine and lixisenatide Subcutaneous-Differin Cream
- Insulin glargine and lixisenatide Subcutaneous-Differin Lotion
- Insulin glargine and lixisenatide Subcutaneous-Differin Topical
- Insulin glargine and lixisenatide Subcutaneous-Dificid